Chronic kidney disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention Group: 57 Person In Intervention Group Will Be Treated From Day After Catheter Insertion With Aspirin 80 mg Daily (All Patients Will Use Aspirin From A Pharmaceutical Comp
Sponsors
Ardabil University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ESRD Patient Requiring Permanent Hemodyalisis Catheter Patients Candidate For Hemodyalisis Catheter Replacement
Exclusion criteria
Exclusion criteria: Blood loss Requiring Either Hospitalization Or Transfusion In The Previous 3 Months Advanced Proliferative Diabetic Retinopathy Life Expectancy 200 mmHg Or Diastolic BP >110 mmHg On Three Different Occasions In A Period Of 2 Weeks Platelet count 1.3 Partial Thromboplastin Time 5 Seconds Longer Than Control Patients Receiving Dipyridamole ,Sulfinpyrazone ,Ticlopidine , Clopidogrel ,Or Nonsteroid Anti-inflammatory Drugs All Bleeding Episode After Aspirin Use Leeding HB Loss>1 Gr/Dl Catheter Dysfunction From Insertion Catheter Site Infection Catheter Replacement More Than 3 Times Previous Coagulopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Catheter Thrombosis. Timepoint: At the begining, Catheter dysfunction in first 3 month. Method of measurement: Direct vision of catheter thrombosis, venous Doppler sonography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Rezazadeh
Ardabil University of Medical Sciences
Outcome results
None listed